CO62 Clinical Outcomes of Second-Line (2L) Treatments (TXS) in Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review (SLR)
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.150
https://www.valueinhealthjournal.com/article/S1098-3015(24)00265-1/fulltext
Title :
CO62 Clinical Outcomes of Second-Line (2L) Treatments (TXS) in Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review (SLR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00265-1&doi=10.1016/j.jval.2024.03.150
First page :
Section Title :
Open access? :
No
Section Order :
10924